X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-12 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $535.96 | -13,466 | 298 | -98% | -$7,217,196 | |||||
| DM | 2024-11-08 | ISRG | Samath Jamie | See Remarks | S - Sale+OE | $525.17 | -23,172 | 8,757 | -73% | -$12,169,305 | |||||
| D | 2024-11-11 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $539.89 | -239 | 5,506 | -4% | -$129,034 | |||||
| D | 2024-10-30 | ISRG | Guthart Gary S | CEO | S - Sale+OE | $511.34 | -25,591 | 1,255,203 | -2% | -$13,085,803 | |||||
| DM | 2024-10-25 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $513.10 | -1,784 | 5,506 | -24% | -$915,371 | |||||
| M | 2024-10-25 | ISRG | Brosius Mark | SVP, Chief Mfg, Supply Cha | S - Sale | $513.83 | -44 | 185 | -19% | -$22,609 | |||||
| DM | 2024-10-22 | ISRG | Brosius Mark | SVP, Chief Mfg, Supply Cha | S - Sale+OE | $514.95 | -2,172 | 229 | -90% | -$1,118,463 | |||||
2024-10-22 | ISRG | Miller Brian Edward | EVP, Chief Digital Officer | S - Sale | $515.00 | -2,553 | 7,066 | -27% | -$1,314,795 | ||||||
2024-09-13 | ISRG | Ladd Amy L | Dir | S - Sale | $490.28 | -450 | 821 | -35% | -$220,626 | ||||||
| D | 2024-09-12 | ISGR | Brosius Mark | See Remarks | S - Sale+OE | $491.91 | -2,115 | 295 | -88% | -$1,040,390 | |||||
| D | 2024-09-10 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $477.50 | -238 | 5,506 | -4% | -$113,645 | |||||
2024-09-09 | ISRG | Loeb Gary | GC | S - Sale | $475.00 | -300 | 1,595 | -16% | -$142,500 | ||||||
| DM | 2024-08-28 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $482.57 | -376 | 5,506 | -6% | -$181,446 | |||||
| D | 2024-08-26 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $486.88 | -396 | 5,506 | -7% | -$192,804 | |||||
| D | 2024-08-23 | ISRG | Charlton Henry L | SVP, Chief Commercial, Mkt | S - Sale+OE | $486.84 | -40,243 | 3,001 | -93% | -$19,591,843 | |||||
| D | 2024-08-12 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $464.76 | -240 | 5,506 | -4% | -$111,542 | |||||
| D | 2024-08-01 | ISRG | Johnson Amal M | Dir | S - Sale+OE | $443.30 | -2,943 | 12,275 | -19% | -$1,304,632 | |||||
| D | 2024-07-30 | ISRG | Guthart Gary S | CEO | S - Sale+OE | $443.56 | -30,828 | 1,255,594 | -2% | -$13,673,996 | |||||
| DM | 2024-07-26 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $440.28 | -1,789 | 5,506 | -25% | -$787,663 | |||||
| D | 2024-07-23 | ISRG | Barratt Craig H | Dir | S - Sale+OE | $458.13 | -1,400 | 26,155 | -5% | -$641,382 | |||||
| D | 2024-07-23 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $458.13 | -2,818 | 298 | -90% | -$1,291,010 | |||||
| D | 2024-06-12 | ISRG | Barratt Craig H | Dir | S - Sale+OE | $421.06 | -1,400 | 26,155 | -5% | -$589,484 | |||||
| D | 2024-06-10 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $416.60 | -239 | 5,506 | -4% | -$99,567 | |||||
| D | 2024-06-05 | ISRG | Barratt Craig H | Dir | S - Sale+OE | $411.00 | -1,400 | 26,155 | -5% | -$575,400 | |||||
| D | 2024-06-03 | ISRG | Barratt Craig H | Dir | S - Sale+OE | $402.89 | -2,496 | 26,155 | -9% | -$1,005,613 | |||||
| DM | 2024-05-28 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $402.51 | -772 | 5,506 | -12% | -$310,734 | |||||
| M | 2024-05-16 | ISRG | Brosius Mark | SVP, Chief Mfg, Supply Cha | S - Sale | $397.73 | -238 | 295 | -45% | -$94,659 | |||||
2024-05-16 | ISRG | Miller Brian Edward | EVP, Chief Digital Officer | S - Sale | $400.00 | -2,553 | 9,619 | -21% | -$1,021,200 | ||||||
| M | 2024-05-13 | ISRG | Brosius Mark | SVP, Chief Mfg, Supply Cha | S - Sale | $385.74 | -525 | 533 | -50% | -$202,515 | |||||
| DM | 2024-05-10 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $387.51 | -523 | 5,506 | -9% | -$202,668 | |||||
| D | 2024-05-03 | ISRG | Rubash Mark J | Dir | S - Sale+OE | $380.00 | -1,709 | 16,051 | -10% | -$649,420 | |||||
| DM | 2024-04-26 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $371.02 | -1,874 | 5,507 | -25% | -$695,293 | |||||
| D | 2024-04-23 | ISRG | Levy Alan J | Dir | S - Sale+OE | $370.70 | -2,000 | 25,319 | -7% | -$741,398 | |||||
| D | 2024-04-23 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $370.66 | -5,318 | 298 | -95% | -$1,971,160 | |||||
| D | 2024-03-15 | ISRG | Widman Fredrik | VP Corporate Controller | S - Sale+OE | $397.07 | -5,041 | 110 | -98% | -$2,001,630 | |||||
| DM | 2024-03-08 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $393.74 | -20,625 | 5,507 | -79% | -$8,120,872 | |||||
| M | 2024-03-08 | ISRG | Brosius Mark | SVP, Chief Mfg, Supply Cha | S - Sale | $391.09 | -392 | 1,058 | -27% | -$153,307 | |||||
| M | 2024-03-05 | ISRG | Brosius Mark | SVP, Chief Mfg, Supply Cha | S - Sale | $393.35 | -588 | 1,450 | -29% | -$231,292 | |||||
2024-03-01 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale | $383.48 | -1,605 | 298 | -84% | -$615,485 | ||||||
| D | 2024-02-28 | ISRG | Mohr Marshall | EVP Global Business S | S - Sale+OE | $385.08 | -108,790 | 149,855 | -42% | -$41,893,066 | |||||
| D | 2024-02-27 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $386.46 | -843 | 298 | -74% | -$325,786 | |||||
| M | 2024-02-14 | ISRG | Brosius Mark | SVP, Chief Mfg, Supply Cha | S - Sale | $380.10 | -92 | 709 | -11% | -$34,969 | |||||
| M | 2024-02-12 | ISRG | Brosius Mark | SVP, Chief Mfg, Supply Cha | S - Sale | $380.80 | -60 | 801 | -7% | -$22,848 | |||||
| D | 2024-02-12 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $386.09 | -481 | 298 | -62% | -$185,709 | |||||
| D | 2024-02-07 | ISRG | Rosa David J. | Pres | S - Sale+OE | $389.28 | -80,710 | 214,389 | -27% | -$31,418,468 | |||||
2024-02-01 | ISRG | Brosius Mark | SVP, Chief Mfg, Supply Cha | S - Sale | $378.41 | -39 | 448 | -8% | -$14,758 | ||||||
| D | 2024-01-29 | ISRG | Guthart Gary S | CEO | S - Sale+OE | $375.78 | -29,285 | 1,267,789 | -2% | -$11,004,743 | |||||
| D | 2024-01-26 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $370.15 | -4,318 | 189 | -96% | -$1,598,298 | |||||
| D | 2024-01-26 | ISRG | Levy Alan J | Dir | S - Sale+OE | $370.20 | -2,000 | 25,319 | -7% | -$740,405 | |||||
| D | 2024-01-26 | ISRG | Johnson Amal M | Dir | S - Sale+OE | $370.08 | -6,696 | 11,706 | -36% | -$2,478,032 | |||||
| D | 2023-11-16 | ISRG | Johnson Amal M | Dir | S - Sale+OE | $300.00 | -9,567 | 11,706 | -45% | -$2,870,100 | |||||
| D | 2023-11-16 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $300.00 | -8,819 | 189 | -98% | -$2,645,700 | |||||
| D | 2023-11-14 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $290.00 | -867 | 7,259 | -11% | -$251,430 | |||||
| D | 2023-11-14 | ISRG | Levy Alan J | Dir | S - Sale+OE | $290.00 | -2,000 | 25,319 | -7% | -$580,000 | |||||
| DM | 2023-10-26 | ISRG | Guthart Gary S | CEO | S - Sale+OE | $261.92 | -32,345 | 1,263,324 | -2% | -$8,471,803 | |||||
| D | 2023-10-24 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $273.49 | -1,110 | 7,259 | -13% | -$303,574 | |||||
2023-09-14 | ISRG | Ladd Amy L | Dir | S - Sale | $305.68 | -500 | 702 | -42% | -$152,840 | ||||||
| D | 2023-08-07 | ISRG | Levy Alan J | Dir | S - Sale+OE | $310.00 | -2,000 | 25,319 | -7% | -$620,000 | |||||
| DM | 2023-07-28 | ISRG | Guthart Gary S | CEO | S - Sale+OE | $326.68 | -55,274 | 1,261,919 | -4% | -$18,057,148 | |||||
| D | 2023-07-25 | ISRG | Desantis Robert | EVP, Chief Strategy, Corp Op | S - Sale+OE | $323.26 | -2,535 | 7,259 | -26% | -$819,460 | |||||
| D | 2023-06-14 | ISRG | Mohr Marshall | EVP Global Business S | S - Sale+OE | $325.00 | -11,250 | 124,489 | -8% | -$3,656,250 | |||||
| D | 2023-06-14 | ISRG | Barratt Craig H | Dir | S - Sale+OE | $322.78 | -1,567 | 25,351 | -6% | -$505,796 | |||||
| D | 2023-06-14 | ISRG | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $325.00 | -2,443 | 7,259 | -25% | -$793,975 | |||||
| D | 2023-05-01 | ISRG | Barratt Craig H | Dir | S - Sale+OE | $306.00 | -2,000 | 25,351 | -7% | -$612,000 | |||||
| D | 2023-04-28 | ISRG | Rubash Mark J | Dir | S - Sale+OE | $300.00 | -7,323 | 15,482 | -32% | -$2,196,900 | |||||
| DM | 2023-04-21 | ISRG | Rosa David J. | EVP Chief Strategy, Growth Of | S - Sale+OE | $298.56 | -81,564 | 155,712 | -34% | -$24,351,619 | |||||
| D | 2023-04-21 | ISRG | Rubash Mark J | Dir | S - Sale+OE | $297.92 | -1,683 | 15,000 | -10% | -$501,401 | |||||
2023-04-21 | ISRG | Rubash Mark J | Dir | S - Sale | $297.93 | -8,135 | 15,000 | -35% | -$2,423,689 | ||||||
2023-04-21 | ISRG | Widman Fredrik | VP Corporate Controller | S - Sale | $297.87 | -630 | 2,233 | -22% | -$187,658 | ||||||
| D | 2023-04-21 | ISRG | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $297.92 | -8,623 | 7,065 | -55% | -$2,568,981 | |||||
| D | 2023-04-21 | ISRG | Barratt Craig H | Dir | S - Sale+OE | $297.92 | -6,000 | 24,696 | -20% | -$1,787,524 | |||||
| D | 2023-04-21 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $299.76 | -9,623 | 327 | -97% | -$2,884,579 | |||||
| D | 2023-03-01 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $228.47 | -1,253 | 1,950 | -39% | -$286,273 | |||||
2023-02-16 | ISRG | Widman Fredrik | VP Corporate Controller | S - Sale | $240.77 | -116 | 1,605 | -7% | -$27,929 | ||||||
| D | 2023-02-16 | ISRG | Curet Myriam | EVP, Chief Medical Officer | S - Sale+OE | $240.77 | -1,124 | 327 | -77% | -$270,625 | |||||
| D | 2023-02-16 | ISRG | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $240.77 | -1,971 | 6,365 | -24% | -$474,558 | |||||
| D | 2023-02-13 | ISRG | Mohr Marshall | EVP Global Business S | S - Sale+OE | $245.61 | -33,249 | 121,104 | -22% | -$8,166,377 | |||||
2023-02-13 | ISRG | Widman Fredrik | VP Corporate Controller | S - Sale | $246.09 | -1,307 | 1,489 | -47% | -$321,640 | ||||||
| D | 2023-02-06 | ISRG | Rosa David J. | EVP Chief Strategy, Growth Of | S - Sale+OE | $250.53 | -45,025 | 125,385 | -26% | -$11,280,023 | |||||
| D | 2023-01-27 | ISRG | Desantis Robert | EVP, Chief Product Officer | S - Sale+OE | $250.00 | -1,629 | 6,769 | -19% | -$407,250 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |